Coffee Break Spotlight 5

Dr. Bassem Toeama

With a few decades of work experiences in various fields of life sciences and multiple transitions in his career, Bassem Toeama dazzled our fifth Coffee Break Spotlight. Bassem is the founder and CEO of MD Pharma Consulting Group. He is a Ph.D. candidate in health technology assessment at the University of Toronto and is a previous team lead of the LSCDS writing team. Bassem’s research areas are oncology, pharmacovigilance, health technology assessment, decision analysis, and benefit-risk assessment. Bassem shared with us at the spotlight interview about the challenges he overcame and his suggestions for trainees on how to make a place in the competitive job market.

An avid learner and a risk-taker, Bassem started his consulting agency during the Covid-19 pandemic. Bassem made timely transitions throughout his career by leveraging his diverse research and pharmaceutical expertise, and his courage towards accepting challenges.

Listen to our full Coffee Break Spotlight to hear more about Bassem’s career path in clinical research, drug development, and entrepreneurship, including some practical advice for trainees on how to run the extra miles to get recognized for their work.

Bassem Toeama graduated in medicine and has worked in clinical medicine as an oncologist, in academia, and in the pharmaceutical industry over the past 25 years. His experience has been primarily in oncology, pharmacovigilance, clinical research, and lab research. He holds an MSc degree in Experimental Therapeutics at the University of Oxford, UK, an MSc degree in Experimental Medicine at McGill University, Canada, and he is a Ph.D. candidate in health technology assessment at the University of Toronto, Canada. Bassem’s areas of research are health technology assessment, decision analysis, and benefit-risk assessment.